First use of intravenous chemotherapy cancer treatment: rectifying the record (J Am Coll Surg 2011;212:413-417) (2011)

Peer-Reviewed Study · Tier 1 — Primary Document · John E. Fenn, Robert Udelsman (Yale Department of Surgery) · March 2011

John E. Fenn et al., 2011-03: The definitive reconstruction of the Yale case from the recovered 1942 chart, correcting earlier published recollections of 'JD'. It sets out the OSRD-to-Yale contract, Lindskog's selection of the patient, the dosing, and the fact that security rules kept the drug's identity out of the record.

The research on nitrogen mustard was censored in accordance with the War Department's security directive, and when it was used for the treatment of cancer in 1942, nowhere in the patient's medical record do the words "nitrogen mustard" appear.

Article body (opened via the NLM record)

John E. Fenn et al., 2011-03: The definitive reconstruction of the Yale case from the recovered 1942 chart, correcting earlier published recollections of 'JD'. It sets out the OSRD-to-Yale contract, Lindskog's selection of the patient, the dosing, and the fact that security rules kept the drug's identity out of the record. Funder: not stated in the accessible text. Conflicts: not stated. Maker: wartime U.S. chemical warfare programme. Comparator: none – single patient, no control. On consent, verbatim: 'This was long before the Nuremberg Code, Belmont Report, or institutional review boards.' Note: PubMed serves the record without an abstract; the article body was readable through the NLM page during this run but the publisher PDF is paywalled. Study type: review.